Evidence map›Paper›PMID 37195936›Full record

ArticlePloS one2023

Vancomycin prescribing and therapeutic drug monitoring: Challenges of real clinical practice.

Mariam Hantash Abdel Jalil, Rima Ηijazeen, Farah Khaled Abu-Mahfouz, Khawla Abu Hammour, Maria Hasan Matalqah, Jwan Saleh Khaleel Albadaineh, Shrouq Khaled AlOmoush, Montaha Al-Iede

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mariam Hantash Abdel JalilDepartment of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.ORCID 0000-0002-3976-5444
Rima ΗijazeenDepartment of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Farah Khaled Abu-MahfouzDepartment of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Khawla Abu HammourDepartment of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Maria Hasan MatalqahSchool of Pharmacy Jordan University of Science and Technology, Irbid, Jordan.
Jwan Saleh Khaleel AlbadainehSchool of Pharmacy Mu'tah University, Kerak, Jordan.
Shrouq Khaled AlOmoushSchool of Pharmacy Jordan University of Science and Technology, Irbid, Jordan.
Montaha Al-IedeDepartment of Pediatrics, Jordan University Hospital, Amman, Jordan.ORCID 0000-0002-7554-7604
University of Jordan · JOJordan University of Science and Technology · JOMutah University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVancomycin prescription and monitoring guidelines have been reported to be poorly followed by various centers.

aimsIdentifying barriers to compliance with vancomycin dosing and therapeutic drug monitoring guidelines (TDM) and possible ways to enhance compliance based on the healthcare providers' (HCPs) perspective.

methodsA qualitative study based on semi-structured interviews with HCP (physicians, pharmacists, and nurses) was conducted at two Jordanian Teaching Hospitals. Interviews were audio-recorded and analyzed through thematic analysis. The COREQ criteria for qualitative research were utilized to report the study findings.

resultsA total of 34 HCPs were interviewed. HCP perceived several factors as barriers to guideline recommendation compliance. Such factors included negative perception towards prescription guidelines, lack of knowledge regarding TDM guidelines, the hierarchy of medication management, work pressure, and ineffective communication among healthcare providers. Potential strategies to optimize guidelines adaptation included providing HCPs with more training and decision support tools in addition to activating the role of clinical pharmacists.

conclusionsThe main barriers to guideline recommendations uptake were identified. Interventions should address those barriers related to the clinical environment, including enhancing interprofessional communication related to vancomycin prescription and TDM, reducing workload and providing support systems, promoting educational and training programs, in addition to adopting guidelines suitable for the local environment.

Indexed as

PhysiciansVancomycinDrug MonitoringHealth PersonnelHumansPharmacistsQualitative ResearchVancomycin

Identifiers

PMID37195936
PMCPMC10191297
OpenAlexW4376959092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.